Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.Published in:Current Treatment Options in Oncology, 2015, v. 16, n. 10, p. 1, doi. 10.1007/s11864-015-0364-2By:Mamdani, Hirva;Jalal, Shadia I.;Hanna, NasserPublication type:Article
Generations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Perils and Progress.Published in:2015By:Castellanos, Emily H;Horn, LeoraPublication type:journal article
Management of Dermatologic Complications of Lung Cancer Therapies.Published in:2015By:Pugliese, Silvina B;Neal, Joel W;Kwong, Bernice YPublication type:journal article
New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer.Published in:2015By:Cameron, Laird;Solomon, BenjaminPublication type:journal article
Targeted Therapy in Biliary Tract Cancers.Published in:2015By:Merla, Amartej;Liu, Kenneth G;Rajdev, LakshmiPublication type:journal article